Publications by authors named "Yohei Tabuchi"

Claim this Profile
P
Population pharmacokinetics and pharmacogenomics of edoxaban in Japanese adults with atrial fibrillation.
Satoshi Ueshima, Daiki Hira, Sayana Matsuda, Rio Michihata, Yohei Tabuchi

J Pharm Health Care Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High incidence of major bleeding with off-label use of edoxaban.
Rika Fukui, Daiki Hira, Yuki Kunitsu, Tetsuichiro Isono, Yohei Tabuchi

J Clin Biochem Nutr· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics and Pharmacodynamics of Apixaban Linking Its Plasma Concentration to Intrinsic Activated Coagulation Factor X Activity in Japanese Patients with Atrial Fibrillation.
Satoshi Ueshima, Daiki Hira, Chiho Tomitsuka, Miki Nomura, Yuuma Kimura, Yohei Tabuchi

AAPS J· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics and pharmacogenomics of apixaban in Japanese adult patients with atrial fibrillation.
Satoshi Ueshima, Daiki Hira, Yuuma Kimura, Ryo Fujii, Chiho Tomitsuka, Yohei Tabuchi

Br J Clin Pharmacol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of ABCB1, ABCG2, and CYP3A5 polymorphisms on plasma trough concentrations of apixaban in Japanese patients with atrial fibrillation.
Satoshi Ueshima, Daiki Hira, Ryo Fujii, Yuuma Kimura, Chiho Tomitsuka, Yohei Tabuchi

Pharmacogenet Genomics· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crystal structures of hydrogen-bonded co-crystals as liquid crystal precursors: 4-(-pent-yloxy)benzoic acid-()-1,2-bis-(pyridin-4-yl)ethene (2/1) and 4-(-hex-yloxy)benzoic acid-()-1,2-bis-(pyridin-4-yl)ethene (2/1).
Yohei Tabuchi, Kazuma Gotoh, Hiroyuki Ishida

Acta Crystallogr E Crystallogr Commun· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crystal structures of four co-crystals of ()-1,2-di(pyridin-4-yl)ethene with 4-alk-oxy-benzoic acids: 4-meth-oxy-benzoic acid-()-1,2-di(pyridin-4-yl)ethene (2/1), 4-eth-oxy-benzoic acid-()-1,2-di(pyridin-4-yl)ethene (2/1), 4--propoxybenzoic acid-()-1,2-di(pyridin-4-yl)ethene (2/1) and 4--but-oxy-benzoic acid-()-1,2-di(pyridin-4-yl)ethene (2/1).
Yohei Tabuchi, Kazuma Gotoh, Hiroyuki Ishida

Acta Crystallogr E Crystallogr Commun· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crystal structures of three co-crystals of 4,4'-bipyridyl with 4-alk-oxy-benzoic acids: 4-eth-oxy-benzoic acid-4,4'-bipyridyl (2/1), 4-n-propoxybenzoic acid-4,4'-bipyridyl (2/1) and 4-n-but-oxy-benzoic acid-4,4'-bipyridyl (2/1).
Yohei Tabuchi, Kazuma Gotoh, Hiroyuki Ishida

Acta Crystallogr E Crystallogr Commun· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crystal structures of three co-crystals of 1,2-bis-(pyridin-4-yl)ethane with 4-alk-oxy-benzoic acids: 4-eth-oxy-benzoic acid-1,2-bis-(pyridin-4-yl)ethane (2/1), 4-n-propoxybenzoic acid-1,2-bis(pyridin-4-yl)ethane (2/1) and 4-n-but-oxy-benzoic acid-1,2-bis-(pyridin-4-yl)ethane (2/1).
Yohei Tabuchi, Kazuma Gotoh, Hiroyuki Ishida

Acta Crystallogr E Crystallogr Commun· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis